Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices.

[1]  O. Howard Frazier,et al.  Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. , 2014, Journal of the American College of Cardiology.

[2]  A. Kfoury,et al.  Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II , 2013, Circulation. Heart failure.

[3]  Yariv N. Marmor,et al.  Readmissions after implantation of axial flow left ventricular assist device. , 2013, Journal of the American College of Cardiology.

[4]  Ranjit John,et al.  Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist Devices , 2012, Circulation.

[5]  F. Pagani,et al.  Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  Robert L Kormos,et al.  The Fourth INTERMACS Annual Report: 4,000 implants and counting. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  N. Uriel,et al.  Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. , 2010, Journal of the American College of Cardiology.

[8]  J. Rogers,et al.  Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. , 2010, The Annals of thoracic surgery.

[9]  M. Slaughter.  Hematologic Effects of Continuous Flow Left Ventricular Assist Devices , 2010, Journal of cardiovascular translational research.

[10]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[11]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[12]  A. Kfoury,et al.  Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection , 2007, Circulation.

[13]  P. Prandoni,et al.  The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. , 2007, Haematologica.

[14]  Sean Pinney,et al.  Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  N. Uriel,et al.  Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombus, and outcomes. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  Nir Uriel,et al.  Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  M. Mehra,et al.  The vexing problem of thrombosis in long-term mechanical circulatory support. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  Nader Moazami,et al.  Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.

[19]  M. Camacho,et al.  Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.